Selpercatinib
About
Therapy type: Targeted therapy
Therapy strategy: RET inhibition
Mappings
NCI Thesaurus: Selpercatinib (coding:ncit:C134987)
RxNorm: selpercatinib (coding:rxcui:2370147, coding:omop:1145791)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) HC (1) | v::RET | Non-Small Cell Lung Cancer | Selpercatinib | |
| FDA (2) HC (1) | RET oncogenic variants | Medullary Thyroid Cancer | Selpercatinib | |
| FDA (2) | v::RET | Anaplastic Thyroid Cancer | Selpercatinib | |
| FDA (2) | v::RET | Any solid tumor | Selpercatinib | |
| HC (1) | v::RET | Papillary Thyroid Cancer | Selpercatinib |